
|Articles|December 1, 2003
Dry eye sufferers may now consider LASIK procedure
New Orleans-Cyclosporine 0.05% ophthalmic emulsion (Restasis, Allergan) appears to be safe and effective in enhancing clinical outcomes in patients with dry eye who wish to undergo LASIK, said George M. Salib, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Beyond the surface: Tackling complex dry eye cases
3
Redefining glaucoma care: Where innovation meets clinical insight
4
An Extreme Case of Demodex Blepharitis: From Misdiagnosis to Remarkable Recovery
5



















































.png)


